TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Single Center Prospective Randomized Control Trial on Negative Pressure Wound Therapy for Primarily Closed Groin Incisions Following Lower-limb Re-vascularization to Reduce Surgical Site Infection
Brief Summary: The purpose of this study is to investigate the current standard of wound care following vascular operations compared to to a negative pressure wound therapy (vacuum dressing) and the rate of surgical site infections (SSIs) in patients undergoing surgery to restore blood flow to the lower limb(s).

Negative pressure wound therapy consists of a closed, sealed system that produces negative pressure (vacuum) to the wound surface. The device itself consists of open-cell foam that is sealed with an occlusive adhesive dressing (covers and sticks to the incision) and suction is maintained by connecting suction tubes to a vacuum pump and waste collector.

The investigators objectives are to determine whether there will be any reduction in surgical site infection and this potential reduction will influence length of hospital stay, emergency room visits, antibiotic use and need for re-operation.


Options:
A: Arm Label: Current Standard; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard Tegaderm (3M Healthcare, St. Paul, MN) adhesive dressing | Arm Label: Negative Pressure Wound Therapy; Type: EXPERIMENTAL; Interventions: Device: Prevena (Negative Pressure Wound Therapy Device) | Intervention Type: DEVICE; Name: Prevena (Negative Pressure Wound Therapy Device); Assigned to Arm(s): Negative Pressure Wound Therapy | Intervention Type: DEVICE; Name: Standard Tegaderm (3M Healthcare, St. Paul, MN) adhesive dressing; Assigned to Arm(s): Current Standard
B: Arm Label: Negative pressure dressing; Type: EXPERIMENTAL; Interventions: Device: Negative pressure dressing | Arm Label: Standard dressing; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard wound dressing | Intervention Type: DEVICE; Name: Negative pressure dressing; Assigned to Arm(s): Negative pressure dressing | Intervention Type: DEVICE; Name: Standard wound dressing; Assigned to Arm(s): Standard dressing
C: Arm Label: Closed Incision Wound vacuum (Prevena); Type: EXPERIMENTAL; Interventions: Device: Closed incision wound vacuum (Prevena) | Arm Label: Routine Wound Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Closed incision wound vacuum (Prevena); Assigned to Arm(s): Closed Incision Wound vacuum (Prevena)
D: Arm Label: Prevena device (Group A); Type: EXPERIMENTAL; Interventions: Device: Prevena device (Group A) | Arm Label: Conventional dressing (Group B); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Prevena device (Group A); Assigned to Arm(s): Prevena device (Group A)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Single Center Prospective Randomized Control Trial on Negative Pressure Wound Therapy for Primarily Closed Groin Incisions Following Lower-limb Re-vascularization to Reduce Surgical Site Infection
Brief Summary: The purpose of this study is to investigate the current standard of wound care following vascular operations compared to to a negative pressure wound therapy (vacuum dressing) and the rate of surgical site infections (SSIs) in patients undergoing surgery to restore blood flow to the lower limb(s).

Negative pressure wound therapy consists of a closed, sealed system that produces negative pressure (vacuum) to the wound surface. The device itself consists of open-cell foam that is sealed with an occlusive adhesive dressing (covers and sticks to the incision) and suction is maintained by connecting suction tubes to a vacuum pump and waste collector.

The investigators objectives are to determine whether there will be any reduction in surgical site infection and this potential reduction will influence length of hospital stay, emergency room visits, antibiotic use and need for re-operation.


Options:
A: Arm Label: Negative Pressure Wound Therapy; Type: EXPERIMENTAL; Interventions: Device: Negative pressure wound therapy | Arm Label: Standard dressing; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Negative pressure wound therapy; Assigned to Arm(s): Negative Pressure Wound Therapy
B: Arm Label: Current Standard; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard Tegaderm (3M Healthcare, St. Paul, MN) adhesive dressing | Arm Label: Negative Pressure Wound Therapy; Type: EXPERIMENTAL; Interventions: Device: Prevena (Negative Pressure Wound Therapy Device) | Intervention Type: DEVICE; Name: Prevena (Negative Pressure Wound Therapy Device); Assigned to Arm(s): Negative Pressure Wound Therapy | Intervention Type: DEVICE; Name: Standard Tegaderm (3M Healthcare, St. Paul, MN) adhesive dressing; Assigned to Arm(s): Current Standard
C: Arm Label: Vacuum Assisted Closure®; Type: EXPERIMENTAL; Interventions: Device: Vacuum Assisted Closure® | Arm Label: Standard conventional wound therapy; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard conventional wound therapy | Intervention Type: DEVICE; Name: Vacuum Assisted Closure®; Assigned to Arm(s): Vacuum Assisted Closure® | Intervention Type: OTHER; Name: Standard conventional wound therapy; Assigned to Arm(s): Standard conventional wound therapy
D: Arm Label: Prevena device (Group A); Type: EXPERIMENTAL; Interventions: Device: Prevena device (Group A) | Arm Label: Conventional dressing (Group B); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Prevena device (Group A); Assigned to Arm(s): Prevena device (Group A)

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of Integrated Care to Decrease Hospitalization and Institutionalization in Community Dwelling Frail Elderly, With Care Coordination Between Physicians, Home Nursing Services and a Community Geriatrics Unit.
Brief Summary: Introduction: Care of frail and dependent elders with multiple chronic conditions is a major challenge for health care systems. The objective of this study is to evaluate the effect of coordinating the existing structures in the private and public sector for the care of frail and dependent persons over age 60, and susceptible of presenting complex bio-psycho-social issues. This approach is aimed at improving the coordination, continuity, quality and efficacy of care in this population, which presents a high risk of hospitalization, emergency room visits, institutionalization and mortality.

Methods: Three-year cluster randomised controlled trial. A control group receiving usual care (follow up by primary care physician and home nursing service) will be compared to an intervention group that will be provided, in addition, in-home multidimensional geriatric assessment with access to a 24h/7 day a week call service, and coordinated long-term follow-up. Survival analyses will be conducted to compare the outcomes between groups.

Primary outcome:

- Hospitalizations: rates of first hospitalization, number, cause and length of stay.

Secondary outcomes:

* Emergency room visits: rates of first visit, number and cause
* Institutionalization: number of patients
* Mortality: rate and number of deaths and place of death (home versus hospital)


Options:
A: Arm Label: Control arm= usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention arm; Type: OTHER; Interventions: Other: intervention | Intervention Type: OTHER; Name: intervention; Assigned to Arm(s): Intervention arm
B: Intervention Type: BEHAVIORAL; Name: Dutch EASYcare Study Geriatric Intermediate Care Programme; Assigned to Arm(s): N/A
C: Arm Label: regular medical care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: The CareWell programme; Type: EXPERIMENTAL; Interventions: Other: The CareWell programme | Intervention Type: OTHER; Name: The CareWell programme; Assigned to Arm(s): The CareWell programme
D: Arm Label: Conventional care, controlgroup; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: integrated health care chain; Type: EXPERIMENTAL; Interventions: Other: integrated health care chain | Intervention Type: OTHER; Name: integrated health care chain; Assigned to Arm(s): integrated health care chain

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of Integrated Care to Decrease Hospitalization and Institutionalization in Community Dwelling Frail Elderly, With Care Coordination Between Physicians, Home Nursing Services and a Community Geriatrics Unit.
Brief Summary: Introduction: Care of frail and dependent elders with multiple chronic conditions is a major challenge for health care systems. The objective of this study is to evaluate the effect of coordinating the existing structures in the private and public sector for the care of frail and dependent persons over age 60, and susceptible of presenting complex bio-psycho-social issues. This approach is aimed at improving the coordination, continuity, quality and efficacy of care in this population, which presents a high risk of hospitalization, emergency room visits, institutionalization and mortality.

Methods: Three-year cluster randomised controlled trial. A control group receiving usual care (follow up by primary care physician and home nursing service) will be compared to an intervention group that will be provided, in addition, in-home multidimensional geriatric assessment with access to a 24h/7 day a week call service, and coordinated long-term follow-up. Survival analyses will be conducted to compare the outcomes between groups.

Primary outcome:

- Hospitalizations: rates of first hospitalization, number, cause and length of stay.

Secondary outcomes:

* Emergency room visits: rates of first visit, number and cause
* Institutionalization: number of patients
* Mortality: rate and number of deaths and place of death (home versus hospital)


Options:
A: Arm Label: Control arm= usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention arm; Type: OTHER; Interventions: Other: intervention | Intervention Type: OTHER; Name: intervention; Assigned to Arm(s): Intervention arm
B: Intervention Type: BEHAVIORAL; Name: Geriatric Resources for Assessment & Care of Elders (GRACE); Assigned to Arm(s): N/A
C: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Other: Mobile Geriatric Team intervention | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Mobile Geriatric Team intervention; Assigned to Arm(s): Intervention group
D: Arm Label: Patient Group 1; Type: EXPERIMENTAL; Interventions: Other: Health TAPESTRY Intervention | Arm Label: Patient Group 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual care | Intervention Type: OTHER; Name: Health TAPESTRY Intervention; Assigned to Arm(s): Patient Group 1 | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Patient Group 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Testing and Linkage to HIV Care in China: A Clustered Randomized Trial
Brief Summary: This study will evaluate the effects of a comprehensive approach (One4All) to increase the percentage of patients that receive their HIV testing results and counseling.

Primary Hypothesis: The One4All approach will increase the proportion of individuals who have completed all tests to confirm HIV diagnosis and received counseling within 30 days of screening HIV+, given they have screened HIV+ on the initial test, from 40% to 60%.


Options:
A: Arm Label: I; Type: ACTIVE_COMPARATOR; Interventions: Drug: Antiretroviral medications | Arm Label: II; Type: EXPERIMENTAL; Interventions: Drug: Antiretroviral medications+Isoniazid prophylaxis | Arm Label: III; Type: EXPERIMENTAL; Interventions: Drug: Antiretroviral medications | Arm Label: IV; Type: EXPERIMENTAL; Interventions: Drug: Antiretroviral medications+Isoniazid prophylaxis | Intervention Type: DRUG; Name: Antiretroviral medications; Assigned to Arm(s): I | Intervention Type: DRUG; Name: Antiretroviral medications+Isoniazid prophylaxis; Assigned to Arm(s): II | Intervention Type: DRUG; Name: Antiretroviral medications; Assigned to Arm(s): III | Intervention Type: DRUG; Name: Antiretroviral medications+Isoniazid prophylaxis; Assigned to Arm(s): IV
B: Arm Label: One4All; Type: EXPERIMENTAL; Interventions: Behavioral: One4All | Arm Label: Standard of Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard of Care | Intervention Type: BEHAVIORAL; Name: One4All; Assigned to Arm(s): One4All | Intervention Type: BEHAVIORAL; Name: Standard of Care; Assigned to Arm(s): Standard of Care
C: Intervention Type: DRUG; Name: Emtricitabine/tenofovir disoproxil fumarate; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Lopinavir/ritonavir; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Stavudine; Assigned to Arm(s): N/A
D: Arm Label: Standard of care; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard of care | Arm Label: Same-day ART initiation with less frequent follow-up visits; Type: EXPERIMENTAL; Interventions: Other: Same-day ART initiation | Intervention Type: OTHER; Name: Same-day ART initiation; Assigned to Arm(s): Same-day ART initiation with less frequent follow-up visits | Intervention Type: OTHER; Name: Standard of care; Assigned to Arm(s): Standard of care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Ketorolac Tromethamine 0.4% and Nepafenac 0.1% for the Prevention of Cystoid Macular Edema After Phacoemulsification: Prospective Randomized Double-masked Study
Brief Summary: To compare the anti-inflammatory efficacy of ketorolac of tromethamine 0.4% and nepafenac 0.1% eye drops for prophylaxis of cystoid macular edema (CME) after small-incision cataract extraction.


Options:
A: Arm Label: NEVANAC; Type: EXPERIMENTAL; Interventions: Drug: Nepafenac ophthalmic suspension, 0.1% (NEVANAC®) | Arm Label: Nepafenac Vehicle; Type: PLACEBO_COMPARATOR; Interventions: Drug: Nepafenac ophthalmic suspension vehicle | Intervention Type: DRUG; Name: Nepafenac ophthalmic suspension, 0.1% (NEVANAC®); Assigned to Arm(s): NEVANAC | Intervention Type: DRUG; Name: Nepafenac ophthalmic suspension vehicle; Assigned to Arm(s): Nepafenac Vehicle
B: Arm Label: NEVANAC; Type: EXPERIMENTAL; Interventions: Drug: Nepafenac ophthalmic suspension, 0.1% (NEVANAC), Drug: Prednisolone acetate ophthalmic suspension (OMNIPRED) | Arm Label: Nepafenac Vehicle; Type: PLACEBO_COMPARATOR; Interventions: Other: Nepafenac ophthalmic suspension vehicle, Drug: Prednisolone acetate ophthalmic suspension (OMNIPRED) | Intervention Type: DRUG; Name: Nepafenac ophthalmic suspension, 0.1% (NEVANAC); Assigned to Arm(s): NEVANAC | Intervention Type: OTHER; Name: Nepafenac ophthalmic suspension vehicle; Assigned to Arm(s): Nepafenac Vehicle | Intervention Type: DRUG; Name: Prednisolone acetate ophthalmic suspension (OMNIPRED); Assigned to Arm(s): NEVANAC, Nepafenac Vehicle
C: Arm Label: Nepafenac; Type: EXPERIMENTAL; Interventions: Drug: Nepafenac | Arm Label: Ketorolac; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ketorolac | Intervention Type: DRUG; Name: Nepafenac; Assigned to Arm(s): Nepafenac | Intervention Type: DRUG; Name: Ketorolac; Assigned to Arm(s): Ketorolac
D: Intervention Type: DRUG; Name: Ketorolac, Prednisolone Acetate; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Exploratory, 12 Week, Randomised, Partially Double-blinded, Placebo-controlled Parallel Group Trial to Explore the Effects of Once Daily Treatments of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination or Tiotropium (Both Delivered by Respimat® Inhaler), Supervised Exercise Training and Behavior Modification on Exercise Capacity and Physical Activity in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Brief Summary: The primary objectives of the study are to explore the effect of treatment with orally inhaled tiotropium + olodaterol fixed dose combination with and without exercise training, and tiotropium comparing to placebo, on top of behavioural modification in improving exercise capacity in patients with COPD


Options:
A: Arm Label: Exercise training on land; Type: OTHER; Interventions: Other: Exercise training | Arm Label: Exercise training on water; Type: OTHER; Interventions: Other: Exercise training | Intervention Type: OTHER; Name: Exercise training; Assigned to Arm(s): Exercise training on land, Exercise training on water
B: Arm Label: COPD education + Usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: COPD education + Usual care | Arm Label: Physical activity self-management; Type: EXPERIMENTAL; Interventions: Behavioral: Physical activity self-management | Intervention Type: BEHAVIORAL; Name: Physical activity self-management; Assigned to Arm(s): Physical activity self-management | Intervention Type: OTHER; Name: COPD education + Usual care; Assigned to Arm(s): COPD education + Usual care
C: Arm Label: Exercise intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise intervention
D: Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo to tiotropium + olodaterol | Arm Label: tiotropium + olodaterol high dose with BM; Type: EXPERIMENTAL; Interventions: Drug: tiotropium +olodaterol | Arm Label: tiotropium; Type: ACTIVE_COMPARATOR; Interventions: Drug: tiotropium | Arm Label: tiotropium + olodaterol with exercise training and BM; Type: EXPERIMENTAL; Interventions: Drug: tiotropium+olodaterol | Intervention Type: DRUG; Name: placebo to tiotropium + olodaterol; Assigned to Arm(s): placebo | Intervention Type: DRUG; Name: tiotropium+olodaterol; Assigned to Arm(s): tiotropium + olodaterol with exercise training and BM | Intervention Type: DRUG; Name: tiotropium +olodaterol; Assigned to Arm(s): tiotropium + olodaterol high dose with BM | Intervention Type: DRUG; Name: tiotropium; Assigned to Arm(s): tiotropium

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Early Telemedicine Training and Counselling After Hospitalization in Patients With Severe Chronic Obstructive Pulmonary Disease: A Feasibility Study
Brief Summary: Chronic obstructive pulmonary disease (COPD) is a widespread disease that can have a major impact on the lives of individuals. An essential element in the treatment of COPD is rehabilitation of which supervised training is an important part. However, not all individuals with severe COPD can participate in the rehabilitation provided by hospitals and municipal training centres due to distance to the training venues and transportation difficulties. The aim of the feasibility study was to evaluate an individualised home based training and counselling programme via video conference to patients with severe COPD after hospitalization with regard to safety, clinical outcomes, patients' perception, organisational aspects and economic aspects.


Options:
A: Arm Label: Self-Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Ergometer Training | Arm Label: Motivation; Type: EXPERIMENTAL; Interventions: Other: Ergometer Training, Other: Motivation | Intervention Type: OTHER; Name: Ergometer Training; Assigned to Arm(s): Motivation, Self-Control | Intervention Type: OTHER; Name: Motivation; Assigned to Arm(s): Motivation
B: Arm Label: Telemedicine training and counselling; Type: EXPERIMENTAL; Interventions: Other: Telemedicine training and counselling | Intervention Type: OTHER; Name: Telemedicine training and counselling; Assigned to Arm(s): Telemedicine training and counselling
C: Arm Label: Home-based pulmonary rehabilitation; Type: EXPERIMENTAL; Interventions: Behavioral: Home-based pulmonary rehabilitation | Arm Label: Hospital-based pulmonary rehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Hospital-based pulmonary rehabilitation | Intervention Type: BEHAVIORAL; Name: Home-based pulmonary rehabilitation; Assigned to Arm(s): Home-based pulmonary rehabilitation | Intervention Type: BEHAVIORAL; Name: Hospital-based pulmonary rehabilitation; Assigned to Arm(s): Hospital-based pulmonary rehabilitation
D: Arm Label: Intervention group "tele-rehabilitation"; Type: EXPERIMENTAL; Interventions: Combination Product: Tele Rehab | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Combination Product: Tele Rehab | Intervention Type: COMBINATION_PRODUCT; Name: Tele Rehab; Assigned to Arm(s): Control, Intervention group "tele-rehabilitation"

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Early Telemedicine Training and Counselling After Hospitalization in Patients With Severe Chronic Obstructive Pulmonary Disease: A Feasibility Study
Brief Summary: Chronic obstructive pulmonary disease (COPD) is a widespread disease that can have a major impact on the lives of individuals. An essential element in the treatment of COPD is rehabilitation of which supervised training is an important part. However, not all individuals with severe COPD can participate in the rehabilitation provided by hospitals and municipal training centres due to distance to the training venues and transportation difficulties. The aim of the feasibility study was to evaluate an individualised home based training and counselling programme via video conference to patients with severe COPD after hospitalization with regard to safety, clinical outcomes, patients' perception, organisational aspects and economic aspects.


Options:
A: Arm Label: Physical exercise training; Type: EXPERIMENTAL; Interventions: Behavioral: Physical exercise training | Arm Label: Cognitive exercise training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive exercise training | Intervention Type: BEHAVIORAL; Name: Physical exercise training; Assigned to Arm(s): Physical exercise training | Intervention Type: BEHAVIORAL; Name: Cognitive exercise training; Assigned to Arm(s): Cognitive exercise training
B: Arm Label: Physical activity; Type: EXPERIMENTAL; Interventions: Behavioral: Physical activity | Arm Label: Usual Care; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Physical activity | Intervention Type: BEHAVIORAL; Name: Physical activity; Assigned to Arm(s): Physical activity, Usual Care
C: Arm Label: Usual Care-Chronic Disease Management; Type: SHAM_COMPARATOR; Interventions: Behavioral: Usual Care | Arm Label: P2E2T2 Program; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: P2E2T2 Program | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Usual Care-Chronic Disease Management | Intervention Type: BEHAVIORAL; Name: P2E2T2 Program; Assigned to Arm(s): P2E2T2 Program
D: Arm Label: Telemedicine training and counselling; Type: EXPERIMENTAL; Interventions: Other: Telemedicine training and counselling | Intervention Type: OTHER; Name: Telemedicine training and counselling; Assigned to Arm(s): Telemedicine training and counselling

Answer: D